NAYA Biosciences to effect 1-for-12 reverse split
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 13 2025
0mins
Reverse Stock Split Announcement: NAYA Biosciences will implement a 1-for-12 reverse stock split effective March 18, resulting in approximately 666,057 shares outstanding and adjusting authorized shares to 4,166,666.
Compliance with Nasdaq Requirements: The reverse stock split aims to help the company meet Nasdaq's minimum bid price requirement of $1.00 per share, though there is no guarantee it will achieve compliance.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
